West nile virus infection in kidney and pancreas transplant recipients in the dallas-fort worth metroplex during the 2012 texas epidemic

Transplantation

Volumn 97, Issue 9, 2014, Pages 953-957

  Yango, Angelito F ^a   Fischbach, Bernard V ^a   Levy, Marlon ^b   Chandrakantan, Arun ^a   Tan, Valerie ^a   Spak, Cedric ^c   Melton, Larry ^a   Rice, Kim ^a   Barri, Yousri ^a   Rajagopal, Arthi ^a   Klintmalm, Goran ^d  

^a Dallas Nephrology Associates   (United States)

^b Baylor All Saints Medical Center   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d Baylor Transplant Institute   (United States)

Author keywords

Intravenous immunoglobulin; Meningoencephalitis; Solid organ transplants; West Nile virus

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MENTAL HEALTH; MIDDLE AGED; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; UNITED STATES; VIRUS IDENTIFICATION; VIRUS INFECTION; WEST NILE FLAVIVIRUS; WEST NILE VIRUS INFECTION; BLOOD; CASE REPORT; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS DISEASE; RISK; WEST NILE FEVER;

ADULT; AGED; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MENINGOENCEPHALITIS; MIDDLE AGED; PANCREAS TRANSPLANTATION; PANCREATIC DISEASES; RENAL INSUFFICIENCY; RISK; TEXAS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84903767761     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000438621.81686.ab     Document Type: Article

References (36)

1. Smithburn KC, Hughes TP, Burke AW, et al. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940; 11: 471.
2. Nash D, Mostashari F, Fine A, et al. West Nile Outbreak Response Working Group. The outbreak of West Nile virus infection in New York City area in 1999. N Eng J Med 2001; 344: 1807.
3. Centers for disease control. 2012 West Nile virus update. Available at: http://www.cdc.gov./ncidod/dvdbid/westnile/. Accessed December 9, 2013.
4. Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 2006; 134: 1325.
5. Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis 2001; 11: 161.
6. http://www.dshs.state.tx.us/news/updates.shtm.
7. Iwamoto M, Jernigan D, Guasch A, et al. Transmission of west nile virus from an organ donor in four transplant recipients. N Eng J Med 2003; 348: 2196.
8. Hardinger K, Miller B, Storch G, et al. West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients. Am J Transplant 2003; 3: 1312.
9. DeSalvo D, Roy-Chaudhury P, Peddi R, et al. West Nile virus encephalitis in organ transplant recipients: Another high risk group for meningoencephalitis and death? Transplantation 2004; 7: 466.
10. Ravindra K, Freifeld A, Kalil A, et al. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 2004; 38: 1257.
11. Kleinschmidt-DeMasters BK, Marder B, Levi M, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients. Arch Neurol 2004; 61: 1210.
12. Wadei H, Alangaden GJ, Sillix DH, et al. West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant 2004; 18: 753.
13. Shepherd JC, Subramanian A, Montgomery RA, et al. West Nile virus encephalitis in a kidney transplant recipient. Am J Transplant 2004; 4: 830.
14. Weskittel PD. West Nile virus infection in a renal transplant recipient. Nephrol Nurs J 2004; 31: 327.
15. Antony S. Severe meningo-encephalitis and death in a renal transplant recipient resulting from West Nile virus infection. J Natl Med Assoc 2004; 96: 1646.
16. Centers for Disease Control and Prevention (CDC). West Nile virus infection in organ transplant recipientsVNew York and Pennsylvania. August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1021.
17. Saquib R, Randall H, Chandrakantan A, et al. West Nile encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin. Am J Kidney Dis 2008; 52: 19.
18. Stein RA, Zarifian A, Paramesh A, et al. West Nile virus in a kidney transplant recipient. Nephrol Nurs J 2010; 37: 301.
19. Koepsell SA, Freifeld AG, Sambol AR. Seronegative naturally acquired West Nile virus encephalitis in a renal and pancreas transplant recipient. Transpl Infect Dis 2010; 12: 459.
20. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based sero-epidemiological survey. Lancet 2001; 358: 261.
21. Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352: 767.
22. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198: 984.
23. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303.
24. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000; 38: 4066.
25. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003; 290: 524
26. Diamond MS, Sitati EM, Friend LD, et al. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 2003; 198: 1853.
27. Suthar M, Diamond M, Gale M. West Nile virus infection and immunity. Nat Rev Microbiol 2013; 11: 115.
28. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8: 107.
29. Crance JM, Scaramozzino N, Jouan A, et al. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 2003; 58: 73.
30. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomized double-blind placebo-controlled trial. Lancet 2003; 361: 821.
31. Shimoni Z, Niven MJ, Pitlick S, et al. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001; 7: 759.
32. Rhee C, Eaton EF, Concepcion W, et al. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature. Transpl Infect Dis 2011; 13: 312.
33. Planitzer C, Modrof J, Kreil T. West Nile virus neutralization by US plasma-derived immunoglobulin products. J Infect Dis 2007; 196: 435.
34. Hamdan A, Green P, Mendelson E, et al. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 2002; 4: 160.
35. Makhoul B, Braun E, Herskovitz M, et al. Hyperimmune gamma-globulin for the treatment of West Nile virus encephalitis. Isr Med Assoc J 2009; 11: 151.
36. Jordan SC, Toyoda M, Kahwaji J, et al. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant 2011; 11: 196.